NEW & MEDIA > APASL 2011 - Bangkok, Thailand

Recently, in Bangkok, Thailand The conference was held the 21st annual Association of Liver Disease Research Asia Pacific (APASL). The conference lasted four days from 17 to 20 February at the Center Queen Sirikit National Convention. Biotechnology company NANOGEN was Vietnam's only pharmaceutical company present at the meeting.


Attending the conference were more than 4,000 professors, doctors, scientific researchers specialized liver from 88 countries worldwide. With the theme "The Future-Light enlightening the future," the conference featured many scientific reports sharing the latest scientific achievements and prospects in the treatment of liver disease .

The conference program covered many topics related to liver disease such as hepatitis, cirrhosis, HCC, fatty liver disease, alcoholic hepatitis, and liver transplantation ... There were many reports in the areas related to viral hepatitis such as virology, immunology, diagnosis, treatment effects of new drugs, resistance management ...

This year's conference had nearly 30 exhibition booths on the treatment of liver disease by groups such as pharmaceutical multinationals Abbott, Novartis, Roche, GlaxoSmithKline, MSD, ... NANOGEN was the only pharmaceutical company from Vietnam present at this exhibition and conference.

NANOGEN company is successful in research and production of biopharmaceutical products used in the treatment of advanced human disease. NANOGEN introduced international experts to high technology products for the treatment of chronic hepatitis: PEGNANO (peg-interferon alfa 2a) and FERONSURE (interferon alfa 2a). Thus, in Vietnam, patients with hepatitis B, C who require chronic drug treatment can now obtain domestically produced drugs of high quality that cost only 1/3 what imported drugs cost.

Biotechnology company NANOGEN is second in the world to successfully produce Peginterferon alfa 2a, interferon conjugated to polyethylaene glycol, an effective and safe treatment for chronic viral hepatitis B or C. This is a significant step for the pharmaceutical biotechnology industry in Vietnam. In addition to responding to local needs for the cure of hepatitis, NANOGEN's products can be used in many countries around the world.


Other news

Molecular and Cell Biology...

For the first time, Nanogen Biopharmaceutical presented a Molecular and Cell Biology book award...

Nguồn lực kiều bào...

công trong sản xuất thuốc đặc trị tại VN, doanh nhân Việt kiều Mỹ,...

Hi-Tech Park considered good...

National Assembly Vice Chairwoman Nguyen Thi Kim Ngan said in her tour to the Hi-Tech Park in Ho...

CPhI Worldwide 2013 – Frankfurt,...

Well-known as an international interactive company in the biopharmaceutical market, Nanogen Biopharmaceutical...